FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Shuren Sees Hybrid Inspection Program Post Covid

[ Price : $8.95]

CDRH director Jeff Shuren tells an industry conference that FDA will likely favor a hybrid inspection program going forward in the...

Guide on Drug Statistical Principles for Clinical Trials

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled E9(R1) Statistical Principles for Clinical Trials: Addendum...

Asthma Drug Study Coordinator Indicted

[ Price : $8.95]

The Justice Department says a federal grand jury indicted a Miami clinical trial coordinator for conspiring to falsify clinical tr...

Appeals Court Affirms Dismissal of Lipitor Diabetes Case

[ Price : $8.95]

The 2nd Circuit Court of Appeals upholds a New York federal courts dismissal of a suit claiming that Pfizer failed to properly war...

Nonclinical Safety Testing Guide for Pediatric Drugs

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled S11 Nonclinical Safety Testing in Support of Development of...

Drug Reproductive Toxicity Testing Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled S5(R3) Detection of Reproductive and Developmental Toxicity...

Medtronic HeartWare HVAD System Recall is Class 1

[ Price : $8.95]

FDA says the Medtronic recall of its HeartWare HVAD system to update instructions for use and the patient manual due to three issu...

J&J Vision PMA OKd for Myopia Contacts

[ Price : $8.95]

FDA approves a Johnson & Johnson Vision PMA for its Acuvue Abiliti Overnight Therapeutic Lenses, the first orthokeratology contact...

Desktop Health 3D Denture Material Cleared

[ Price : $8.95]

FDA clears a Desktop Health 510(k) for its Flexcera Base, a proprietary resin for use in 3D fabrication of dental prosthetics.

Drug Guide on Q12 Technical and Regulatory Considerations

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Q12 Technical and Regulatory Considerations for Pharmaceuti...